Revelation Biosciences, Inc. SEC filings REVB
Revelation Biosciences, Inc. has 389 filings in SEC EDGAR's recent list, going back to May 14, 2020. Its latest annual report, Form ARS, was filed on May 11, 2026 for the period ended May 11, 2026. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Results of operations
|
Nov 5, 2026 | Nov 5, 2026 |
| 10-Q | Quarterly report | Nov 5, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Officer or director change
|
Aug 19, 2026 | Aug 17, 2026 |
| 4 | Insider transaction | Aug 18, 2026 | Aug 17, 2026 |
| 4 | Insider transaction | Aug 18, 2026 | Aug 17, 2026 |
| 4 | Insider transaction | Aug 18, 2026 | Aug 17, 2026 |
| 4 | Insider transaction | Aug 18, 2026 | Aug 17, 2026 |
| 4 | Insider transaction | Aug 18, 2026 | Aug 17, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2026 | — |
| 8-K |
Current report
Results of operations
|
Aug 6, 2026 | Aug 6, 2026 |
| 10-Q | Quarterly report | Aug 6, 2026 | Jun 30, 2026 |
| 8-A12B | Filing | Jul 13, 2026 | — |
| 8-K |
Current report
Material agreement, Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
|
Jul 13, 2026 | Jul 10, 2026 |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results
|
Jun 24, 2026 | Jun 24, 2026 |
| 8-K |
Current report
Other events
|
Jun 1, 2026 | Jun 1, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | May 15, 2026 | — |
| DEF 14A | Proxy statement | May 11, 2026 | Jun 24, 2026 |
| ARS | Annual report to shareholders | May 11, 2026 | May 11, 2026 |
| 8-K |
Current report
Results of operations
|
May 7, 2026 | May 7, 2026 |
| 10-Q | Quarterly report | May 7, 2026 | Mar 31, 2026 |
| 4 | Insider transaction | May 1, 2026 | Apr 30, 2026 |
| 4 | Insider transaction | May 1, 2026 | Apr 30, 2026 |
| PRE 14A | Preliminary proxy statement | Apr 30, 2026 | Jun 24, 2026 |
| S-8 | Employee stock plan registration | Apr 15, 2026 | — |
| 8-K |
Current report
Change to shareholder rights, Shareholder vote results
|
Mar 19, 2026 | Mar 18, 2026 |
| 8-K |
Current report
Results of operations
|
Feb 26, 2026 | Nov 6, 2025 |
| 10-K | Annual report | Feb 26, 2026 | Dec 31, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 17, 2026 | — |
| DEF 14A | Proxy statement | Feb 17, 2026 | Feb 14, 2026 |
| EFFECT | Filing | Feb 11, 2026 | — |
| 424B3 | Prospectus | Feb 11, 2026 | — |
| CORRESP | Letter to the SEC | Feb 9, 2026 | — |
| PRE 14A | Preliminary proxy statement | Feb 6, 2026 | Feb 6, 2026 |
| UPLOAD | Letter from the SEC | Feb 6, 2026 | — |
| 4 | Insider transaction | Feb 5, 2026 | Feb 3, 2026 |
| 4 | Insider transaction | Feb 5, 2026 | Feb 3, 2026 |
| 4 | Insider transaction | Feb 5, 2026 | Feb 3, 2026 |
| 4 | Insider transaction | Feb 5, 2026 | Feb 3, 2026 |
| 4 | Insider transaction | Feb 5, 2026 | Feb 4, 2026 |
| S-3 | Shelf registration | Jan 30, 2026 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Change to shareholder rights
|
Jan 29, 2026 | Jan 26, 2026 |
| 8-K |
Current report
Other events
|
Jan 22, 2026 | Jan 21, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jan 20, 2026 | — |
| 4 | Insider transaction | Jan 12, 2026 | Jan 8, 2026 |
| 4 | Insider transaction | Jan 12, 2026 | Jan 8, 2026 |
| 4 | Insider transaction | Jan 12, 2026 | Jan 8, 2026 |
| 4 | Insider transaction | Jan 12, 2026 | Jan 8, 2026 |
| 4 | Insider transaction | Jan 12, 2026 | Jan 8, 2026 |
| 8-K |
Current report
Change to shareholder rights, Shareholder vote results, Other events
|
Dec 3, 2025 | Dec 3, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Nov 14, 2025 | — |
| S-8 | Employee stock plan registration | Nov 12, 2025 | — |
| DEF 14A | Proxy statement | Nov 10, 2025 | Dec 3, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2025 | Nov 6, 2025 |
| 10-Q | Quarterly report | Nov 6, 2025 | Sep 30, 2025 |
| 4 | Insider transaction | Oct 31, 2025 | Oct 29, 2025 |
| 4 | Insider transaction | Oct 31, 2025 | Oct 29, 2025 |
| 4 | Insider transaction | Oct 31, 2025 | Oct 29, 2025 |
| 4 | Insider transaction | Oct 31, 2025 | Oct 29, 2025 |
| 4 | Insider transaction | Oct 31, 2025 | Oct 29, 2025 |
| PRE 14A | Preliminary proxy statement | Oct 30, 2025 | Oct 30, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 29, 2025 | Oct 29, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 15, 2025 | Oct 15, 2025 |
| EFFECT | Filing | Sep 30, 2025 | — |
| 424B3 | Prospectus | Sep 30, 2025 | — |
| S-3/A | Filing | Sep 30, 2025 | — |
| CORRESP | Letter to the SEC | Sep 29, 2025 | — |
| CORRESP | Letter to the SEC | Sep 29, 2025 | — |
| UPLOAD | Letter from the SEC | Sep 24, 2025 | — |
| DEF 14A | Proxy statement | Sep 22, 2025 | Sep 22, 2025 |
| S-3 | Shelf registration | Sep 16, 2025 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Change to shareholder rights, Other events
|
Sep 15, 2025 | Sep 11, 2025 |
| PRE 14A | Preliminary proxy statement | Sep 12, 2025 | Sep 11, 2025 |
| 8-K |
Current report
Other events
|
Sep 9, 2025 | Sep 9, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2025 | Aug 8, 2025 |
| 10-Q | Quarterly report | Aug 8, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Other events
|
Jul 9, 2025 | Jul 7, 2025 |
| 8-K |
Current report
Shareholder vote results, Other events
|
Jun 25, 2025 | Jun 23, 2025 |
| DEF 14A | Proxy statement | Jun 9, 2025 | May 29, 2025 |
| 8-K |
Current report
Material agreement, Change to shareholder rights, Other events
|
Jun 4, 2025 | May 28, 2025 |
| PRE 14A | Preliminary proxy statement | May 29, 2025 | May 28, 2025 |
| 424B3 | Prospectus | May 29, 2025 | — |
| EFFECT | Filing | May 28, 2025 | — |
| 8-K |
Current report
Officer or director change, Other events
|
May 28, 2025 | May 23, 2025 |
| CORRESP | Letter to the SEC | May 23, 2025 | — |
| S-1/A | Amended registration statement | May 23, 2025 | — |
| CORRESP | Letter to the SEC | May 22, 2025 | — |
| CORRESP | Letter to the SEC | May 22, 2025 | — |
| UPLOAD | Letter from the SEC | May 21, 2025 | — |
| CORRESP | Letter to the SEC | May 20, 2025 | — |
| S-1 | Registration statement | May 20, 2025 | — |
| 8-K |
Current report
Results of operations
|
May 8, 2025 | May 8, 2025 |
| 10-Q | Quarterly report | May 8, 2025 | Mar 31, 2025 |
| UPLOAD | Letter from the SEC | Apr 9, 2025 | — |
| DRS | Filing | Apr 4, 2025 | — |
| 8-K |
Current report
Other events
|
Mar 17, 2025 | Mar 17, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 6, 2025 | Mar 6, 2025 |
| 10-K | Annual report | Mar 6, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Other events
|
Feb 24, 2025 | Feb 19, 2025 |
| 4 | Insider transaction | Feb 13, 2025 | Feb 11, 2025 |
| 4 | Insider transaction | Feb 13, 2025 | Feb 11, 2025 |
| 4 | Insider transaction | Feb 13, 2025 | Feb 11, 2025 |
| 4 | Insider transaction | Feb 13, 2025 | Feb 11, 2025 |
| 4 | Insider transaction | Feb 13, 2025 | Feb 11, 2025 |
| 4 | Insider transaction | Feb 13, 2025 | Feb 11, 2025 |
| 8-K |
Current report
Other events
|
Feb 11, 2025 | Feb 10, 2025 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change
|
Jan 30, 2025 | Jan 28, 2025 |
| 8-K |
Current report
Shareholder vote results, Other events
|
Jan 21, 2025 | Jan 17, 2025 |
| DEFA14A | Additional proxy material | Jan 13, 2025 | — |
| 8-K |
Current report
Listing notice, Other events
|
Jan 7, 2025 | Jan 3, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jan 2, 2025 | — |
| EFFECT | Filing | Dec 20, 2024 | — |
| 424B3 | Prospectus | Dec 20, 2024 | — |
| CORRESP | Letter to the SEC | Dec 20, 2024 | — |
| CORRESP | Letter to the SEC | Dec 19, 2024 | — |
| S-3/A | Filing | Dec 19, 2024 | — |
| UPLOAD | Letter from the SEC | Dec 18, 2024 | — |
| DEF 14A | Proxy statement | Dec 16, 2024 | Dec 13, 2024 |
| 8-K |
Current report
Other events
|
Dec 12, 2024 | Dec 12, 2024 |
| S-3 | Shelf registration | Dec 12, 2024 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Change to shareholder rights, Other events
|
Dec 6, 2024 | Dec 3, 2024 |
| PRE 14A | Preliminary proxy statement | Dec 5, 2024 | Dec 3, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 8, 2024 | Nov 8, 2024 |
| 10-Q | Quarterly report | Nov 8, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Listing notice
|
Oct 21, 2024 | Oct 16, 2024 |
| 8-K |
Current report
Other events
|
Sep 27, 2024 | Sep 24, 2024 |
| UPLOAD | Letter from the SEC | Sep 25, 2024 | — |
| 10-Q/A | Amended quarterly report | Sep 23, 2024 | Jun 30, 2024 |
| 10-Q/A | Amended quarterly report | Sep 23, 2024 | Mar 31, 2024 |
| 10-K/A | Amended annual report | Sep 23, 2024 | Dec 31, 2023 |
| CORRESP | Letter to the SEC | Sep 23, 2024 | — |
| 424B3 | Prospectus | Sep 13, 2024 | — |
| UPLOAD | Letter from the SEC | Sep 13, 2024 | — |
| EFFECT | Filing | Sep 12, 2024 | — |
| CORRESP | Letter to the SEC | Sep 10, 2024 | — |
| UPLOAD | Letter from the SEC | Sep 9, 2024 | — |
| S-3 | Shelf registration | Sep 3, 2024 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Change to shareholder rights, Other events
|
Aug 26, 2024 | Aug 21, 2024 |
| 8-K |
Current report
Listing notice
|
Aug 19, 2024 | Aug 14, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 9, 2024 | Aug 9, 2024 |
| 10-Q | Quarterly report | Aug 9, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Other events
|
Aug 2, 2024 | Aug 1, 2024 |
| EFFECT | Filing | Jul 26, 2024 | — |
| CORRESP | Letter to the SEC | Jul 23, 2024 | — |
| UPLOAD | Letter from the SEC | Jul 23, 2024 | — |
| S-3 | Shelf registration | Jul 19, 2024 | — |
| 8-K |
Current report
Other events
|
Jun 24, 2024 | Jun 24, 2024 |
| S-8 | Employee stock plan registration | Jun 18, 2024 | — |
| 8-K |
Current report
Shareholder vote results
|
May 16, 2024 | May 15, 2024 |
| 8-K |
Current report
Results of operations
|
May 10, 2024 | May 10, 2024 |
| 10-Q | Quarterly report | May 10, 2024 | Mar 31, 2024 |
| DEF 14A | Proxy statement | Apr 16, 2024 | Apr 15, 2024 |
| PRE 14A | Preliminary proxy statement | Apr 5, 2024 | Apr 5, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 22, 2024 | Mar 22, 2024 |
| 10-K | Annual report | Mar 22, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Mar 12, 2024 | Mar 12, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 13, 2024 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 12, 2024 | — |
| 8-K |
Current report
Material agreement, Change to shareholder rights, Other events
|
Feb 8, 2024 | Feb 5, 2024 |
| 424B3 | Prospectus | Feb 2, 2024 | — |
| EFFECT | Filing | Jan 31, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 30, 2024 | Jan 30, 2024 |
| CORRESP | Letter to the SEC | Jan 30, 2024 | — |
| S-1/A | Amended registration statement | Jan 30, 2024 | — |
| S-1/A | Amended registration statement | Jan 29, 2024 | — |
| CORRESP | Letter to the SEC | Jan 29, 2024 | — |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change
|
Jan 23, 2024 | Jan 22, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jan 22, 2024 | Jan 17, 2024 |
| SC 13G | Ownership over 5% (passive) | Jan 3, 2024 | — |
| UPLOAD | Letter from the SEC | Jan 2, 2024 | — |
| DEF 14A | Proxy statement | Dec 22, 2023 | Dec 22, 2023 |
| S-1 | Registration statement | Dec 22, 2023 | — |
| PRE 14A | Preliminary proxy statement | Dec 12, 2023 | Dec 12, 2023 |
| 4 | Insider transaction | Dec 12, 2023 | Dec 8, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2023 | Nov 13, 2023 |
| 10-Q | Quarterly report | Nov 9, 2023 | Sep 30, 2023 |
| 4 | Insider transaction | Oct 18, 2023 | Oct 16, 2023 |
| 4 | Insider transaction | Oct 17, 2023 | Oct 16, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 12, 2023 | Oct 12, 2023 |
| 3 | Initial insider ownership | Oct 2, 2023 | Sep 27, 2023 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Oct 2, 2023 | Sep 27, 2023 |
| 4 | Insider transaction | Oct 2, 2023 | Sep 28, 2023 |
| 144 | Notice of proposed sale | Sep 28, 2023 | — |
| 4 | Insider transaction | Sep 18, 2023 | Sep 14, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2023 | Aug 11, 2023 |
| S-8 | Employee stock plan registration | Aug 11, 2023 | — |
| 10-Q | Quarterly report | Aug 11, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Listing notice
|
Aug 11, 2023 | Aug 8, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jul 14, 2023 | Jul 14, 2023 |
| DEFA14A | Additional proxy material | Jul 7, 2023 | — |
| 8-K |
Current report
Bylaw or fiscal year change
|
Jul 7, 2023 | Jul 6, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 29, 2023 | Jun 29, 2023 |
| DEFA14A | Additional proxy material | Jun 15, 2023 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 12, 2023 | Jun 12, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
May 25, 2023 | May 25, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 22, 2023 | May 22, 2023 |
| 10-Q | Quarterly report | May 22, 2023 | Mar 31, 2023 |
| NT 10-Q | Filing | May 15, 2023 | Mar 31, 2023 |
| DEF 14A | Proxy statement | May 5, 2023 | May 5, 2023 |
| PRE 14A | Preliminary proxy statement | Apr 25, 2023 | Apr 25, 2023 |
| 4 | Insider transaction | Apr 19, 2023 | Apr 17, 2023 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- REVB (Nasdaq), REVBW (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- San Diego, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1810560
- Former names
- Petra Acquisition Inc. (until Jan 11, 2022)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.